# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-06-04)

**Core value:** A capital-planning analyst can defensibly rank 400m cells for intervention, with every scoring and modeling choice traceable and stress-tested.
**Current focus:** Phase 1 — Return to Brief & Quantitative Robustness

## Current Position

Phase: 1 of 3 (Return to Brief & Quantitative Robustness)
Plan: 0 of 2 in current phase
Status: Ready to plan
Last activity: 2026-06-04 — Roadmap rebuilt to CRISP-DM Phase 5 (Evaluation) rubric; 23 requirements mapped across 3 coarse phases

Progress: [░░░░░░░░░░] 0%

## Performance Metrics

**Velocity:**
- Total plans completed: 0
- Average duration: — min
- Total execution time: 0.0 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| - | - | - | - |

**Recent Trend:**
- Last 5 plans: —
- Trend: —

*Updated after each plan completion*

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- Session 5 = CRISP-DM **Phase 5: Evaluation** per the Session 5 lecture rubric (lecture > skill, locked). The prior "close Phase 4" framing was wrong and has been overwritten.
- HYBRID project: Track A (linear regression = supporting evidence) + Track B (priority ranking / PRPI composite = headline conclusion). Both must be evaluated.
- Grade rewards rigor + honesty, not predictive accuracy. Documented negatives and ruled-out threats are wins.
- Coarse granularity, YOLO mode — 3 broad phases, ~2 plans each.
- Phase 1 (quantitative re-tests) and Phase 2 (qualitative audit + threats + reproducibility) are partly independent and may overlap; Phase 3 (verdict + docs) consumes both and runs last.

### Pending Todos

[From .planning/todos/pending/ — ideas captured during sessions]

None yet.

### Blockers/Concerns

[Issues that affect future work]

- Pre-registration is BINDING: every test in `phase-4/test-design.md` (§4 sensitivity, §5 validity, §6 stability) MUST run and report, including unfriendly results. Silently dropping a pre-registered test is the cardinal Phase 4/5 sin.
- Frozen inputs: all work is analysis-only over `scored_grid.parquet`, `model_artifact.joblib`, the existing splits, and predictions. No re-derivation of Phases 1-3, no new ingestion, no decision-facing UI (deferred to Phase 6).
- Substantive finding to defend: eval R² 0.999 → test R² 0.877 is the honest spatial generalization cost; the composite is a locally near-linear re-skin of `mean_sealed` whose calibration depends on the geographic mix of training cells.
- Windows cp1252 console — set `PYTHONIOENCODING=utf-8` for any non-ASCII `print()`.

## Deferred Items

Items acknowledged and carried forward:

| Category | Item | Status | Deferred At |
|----------|------|--------|-------------|
| Deployment | CRISP-DM Phase 6 / decision-facing UI (DEPL-01) | Deferred to v2 | 2026-06-04 |
| Validation | Cross-data / peri-urban OOD patch (XVAL-01) | Deferred to v2 (no dataset in pipeline) | 2026-06-04 |

## Session Continuity

Last session: 2026-06-04
Stopped at: Roadmap rebuilt to Phase 5 Evaluation rubric; traceability updated; ready to plan Phase 1
Resume file: None
